“…In all patients, we measured the following parameters: blood pressure, HR, Kerdo index, functional alteration index (FAI), Hildebrandt index, heart rate variability (HRV), and CRS index assessed according to [7,10]. They were recorded initially, at the peak of drug action (acute probe), after 6 weeks and after 6 months in the subgroup of patients, in whom the target level of blood pressure was attained (69.6%).…”